Company News - Company Data
Neptune Confirms Its Pre-eminence in the Australian Market
Posted 2012-05-08 00:13
NAI Editing
announces that Aker Biomarine's newly granted Australian patent (AU2008231570) has no impact on Neptune's position as the leading krill oil provider to the Australian market. Neptune Signs John Elway, NFL Hall-of-Famer, as Official Brand Ambassador
Posted 2012-03-27 00:57
NAI Editing
is very excited to announce that the company has entered into a multi-year partnership with former NFL (National Football League) Super Bowl Champion and Hall-of Fame quarterback, John Elway. Neptune Appoints New IR Firm for the US
Posted 2012-03-27 00:56
NAI Editing
today announces that it has appointed Platinum VIII Investements & Media LLC. ("Platinum") as investor relation ("IR") firm for the United States ("US"). Neptune Technologies & Bioressources Investing Over $20M in Sherbrooke
Posted 2012-03-09 01:27
NAI Editing
is to triple its production capacity of its plant by enlarging its facilities on Pepin Street. The first phase is expected to be completed by November 2012, the excavation began last December.Neptune Acquires Common Shares of Acasti Pharma
Posted 2012-02-13 01:14
NAI Editing
announces that on February 10, 2012 it acquired 750,000 newly issued Class "A" common shares (the "Shares") in the capital of Acasti Pharma Inc. (TSX-V:APO) ("Acasti"), a subsidiary of Neptune.Neptune Reports Third Quarter Results
Posted 2012-01-17 02:20
NAI Editing
today reports its consolidated financial results for the three-month and nine-month periods ended November 30, 2011. Three-month Ended November 30, 2011 Financial ResultsNeptune Pursues Its IP Strategy With Continuation Applications
Posted 2012-01-12 01:49
NAI Editing
announced that it has several "Continuation" applications pending in the U.S. Patent & Trademark Office related to U.S. Pat. No.8,030,348 (the "'348 patent") and U.S. Pat.Neptune Starts Phase-I Sherbrooke Plant Expansion
Posted 2011-12-12 00:45
NAI Editing
announces the official start of its Phase I plant expansion, generating within a year an additional production capacity of more than 150,000kg per year. Neptune Reports Preliminary Revenues on Record Quarter
Posted 2011-12-01 02:04
NAI Editing
today provided revenue guidance for the third quarter of Fiscal 2012 ended November 30th. Neptune Preliminary Revenues Neptune Technologies & Bioressources Common Shares Graduate to the TSX
Posted 2011-11-24 11:56
NAI Editing
is pleased to announce that following its news release dated October 27, 2011, the Corporation's common shares have been approved for listing on the TSX and will commence trading on Monday, November 2
Posted 2012-05-08 00:13
announces that Aker Biomarine's newly granted Australian patent (AU2008231570) has no impact on Neptune's position as the leading krill oil provider to the Australian market. Neptune Signs John Elway, NFL Hall-of-Famer, as Official Brand Ambassador
Posted 2012-03-27 00:57
is very excited to announce that the company has entered into a multi-year partnership with former NFL (National Football League) Super Bowl Champion and Hall-of Fame quarterback, John Elway. Neptune Appoints New IR Firm for the US
Posted 2012-03-27 00:56
today announces that it has appointed Platinum VIII Investements & Media LLC. ("Platinum") as investor relation ("IR") firm for the United States ("US"). Neptune Technologies & Bioressources Investing Over $20M in Sherbrooke
Posted 2012-03-09 01:27
is to triple its production capacity of its plant by enlarging its facilities on Pepin Street. The first phase is expected to be completed by November 2012, the excavation began last December.Neptune Acquires Common Shares of Acasti Pharma
Posted 2012-02-13 01:14
announces that on February 10, 2012 it acquired 750,000 newly issued Class "A" common shares (the "Shares") in the capital of Acasti Pharma Inc. (TSX-V:APO) ("Acasti"), a subsidiary of Neptune.Neptune Reports Third Quarter Results
Posted 2012-01-17 02:20
today reports its consolidated financial results for the three-month and nine-month periods ended November 30, 2011. Three-month Ended November 30, 2011 Financial ResultsNeptune Pursues Its IP Strategy With Continuation Applications
Posted 2012-01-12 01:49
announced that it has several "Continuation" applications pending in the U.S. Patent & Trademark Office related to U.S. Pat. No.8,030,348 (the "'348 patent") and U.S. Pat.Neptune Starts Phase-I Sherbrooke Plant Expansion
Posted 2011-12-12 00:45
announces the official start of its Phase I plant expansion, generating within a year an additional production capacity of more than 150,000kg per year. Neptune Reports Preliminary Revenues on Record Quarter
Posted 2011-12-01 02:04
today provided revenue guidance for the third quarter of Fiscal 2012 ended November 30th. Neptune Preliminary Revenues Neptune Technologies & Bioressources Common Shares Graduate to the TSX
Posted 2011-11-24 11:56
is pleased to announce that following its news release dated October 27, 2011, the Corporation's common shares have been approved for listing on the TSX and will commence trading on Monday, November 2


